Nucleic acid therapeutics, such as antisense oligonucleotides (ASOs), have emerged as promising platforms for treating a ...

A new review proposes the Iron-Brain Nexus framework to explain why the brain is uniquely vulnerable to iron-dependent ...

These neurons inhabit the hypothalamus, a brain region tucked behind the eyes. Once released, orexins lock, depending on ...

T-MAXIMUM PHARMACEUTICAL ("T-MAXIMUM") today announced that the U.S. Food and Drug Administration (FDA) has cleared the company to initiate a Phase 2 clinical study of MT027, its internally developed, ...

Spread the love“`html Imagine a future where we could proactively shield our brains from the ravages of Alzheimer’s disease, ...

Oncopeptides Reports Blood-Brain Barrier Penetration in Glioblastoma INSULA Study / blood-brain barrier, brain cancer, cancer ...

Oncopeptides AB (publ) (Nasdaq Stockholm: ONCO), a biotech company specializing in difficult-to-treat cancers, today announces data from the first patients in its ongoing clinical ...

Psilocybin reduced brain swelling and restored more normal blood vessel function after concussion. Study shows psilocybin ...

Coverage of a new PCSK9 trial makes bold claims about prevention and risk reduction. But how well do they hold up to scrutiny ...

Oncopeptides AB (publ), a biotech company specializing in difficult-to-treat cancers, today announces data from the first patients in its ongoing clinical Window-of-Opportunity (WoO) study, OP-701 ...

Research company Oncopeptides reports positive initial results from the ongoing Insula clinical study, which is evaluating the company's PDC drug platform for the treatment of glioblastoma, an ...

The review examines how engineered nanoparticles and predictive tools, including PK/PD, PBPK, CFD, and AI/ML models, could ...